Part D results
CMS's year-end Part D reconciliation, 2022–2024. When a plan's actual drug costs land well above its bid, CMS shares the loss through risk sharing (the "risk corridors"); when they land well below, the plan pays CMS back. A large positive amount means the plan's drug bid was badly underpriced. 2024 is the latest year CMS has published.
How to read this
Risk sharing: positive = CMS paid the plan (costs ran over the bid by more than the corridor); negative = the plan paid CMS. These are CMS's settled figures. Plans also report risk sharing in their MLR filings, sometimes as an estimate made before CMS settled, so a filing can differ.
Per member per year: risk sharing ÷ Part D member-months × 12. Part D member-months include stand-alone drug plan (PDP) members.
CMS's reconciliation also settles reinsurance (catastrophic drug costs) and low-income cost sharing; those are pass-through subsidies, not a sign of profit or loss, so they're shown on contract pages only.
| 2024 | 2023 | 2022 | 3-year total | Per member per year2024 | Part D members2024 avg | |
|---|---|---|---|---|---|---|
| H8889 Medica | $7.3M | $707K | $301K | $8.3M | $148 | 48,998 |
| H2450 Medica | $1.1M | $246K | $226K | $1.5M | $15 | 74,242 |
| H9952 Medica | $340K | $439K | $287K | $1.1M | $177 | 1,923 |
| H2458 Medica | $39.3K | $282K | $86.5K | $407K | $4 | 10,159 |
| H6154 Medica | $266K | $93.8K | $42.4K | $402K | $264 | 1,005 |
| H8019 Medica | −$2.9K | $55.5K | $78.1K | $131K | −$7 | 420 |
| H3632 Medica | — | $35.8K | $91.8K | $128K | — | — |
| S9701 Navitus MedicareRx PDP | $0 | $0 | $0 | $0 | $0 | 96,949 |
| H0798 Medica | — | −$32.1K | −$18.4K | −$50.5K | — | — |
| H9096 Dean Advantage | −$201K | −$46.9K | −$56.2K | −$304K | −$21 | 9,806 |
Red = CMS paid the plan. Sorted by the 3-year total. Parent totals add up each contract under its current parent; CMS also publishes its own parent rollup, which can differ where contracts changed hands.